Skip to main content
Ali Madani, MD, Oncology, Tucson, AZ, Carondelet St. Joseph's Hospital

AliAlainMadaniMDPhD

Oncology Tucson, AZ

Hematology & Oncology Specialist

Dr. Madani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Madani's full profile

Already have an account?

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 2000 - 2003
  • Sparrow Hospital/Michigan State University
    Sparrow Hospital/Michigan State UniversityResidency, Internal Medicine, 1997 - 2000
  • University of Paris VII
    University of Paris VIIPhD, Molecular Biology of Cancer, 1993 - 1996
  • University of Paris
    University of ParisPh.D., Molecular Biology of Cancer, 1993 - 1996
  • University of Paris
    University of ParisMaster's, Biostatistics, 1993 - 1994
  • Univer Algiers- Fac Med
    Univer Algiers- Fac MedClass of 1988

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2023 - 2026
  • HI State Medical License
    HI State Medical License 2020 - 2026
  • IL State Medical License
    IL State Medical License 2023 - 2026
  • CA State Medical License
    CA State Medical License 2020 - 2026
  • CO State Medical License
    CO State Medical License 2020 - 2025
  • WA State Medical License
    WA State Medical License 2020 - 2025
  • MT State Medical License
    MT State Medical License 2023 - 2025
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology
  • Join now to see all

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
  • Merit Award ASCO, 2003
  • First rank at the French National Internship Competition For Foreign Medical Graduates 1989

Publications & Presentations

PubMed

Journal Articles

  • Phase II study of Imatinib Mesylate in chemotherapy refractory Germ Cell Tumors expressing KIT  
    Einhorn L, Brames M, Heinrich M, Corless C, American Journal of Clinical Oncology, 1/1/2006
  • Expression of KIT and Epidermal Growth factor (EGFR) in Chemotherapy Refractory Non-Seminomatous Germ Cell Tumors  
    Kemmer K, Corless C, Ulbright T, Heinrich M, Einhorn L, Annals of Oncology, 1/1/2003
  • New perspective in non-transplant strategies for chronic myelogenous leukemia  
    Madani A, Fellow Reporter, 1/1/2001
  • Join now to see all

Abstracts/Posters

  • Phase II study of Epirubicin plus Cisplatin in refractory germ cell tumors
    Madani A, Annual meeting of the American Society of Clinical Oncology, Orlando, FL, 1/1/2003
  • Expression of KIT and Epidermal Growth Factor receptor EGFR in chemotherapy-refractory germ cell tumors
    Madani A, Annual meeting of the American Society of Clinical Oncology, Orlando, FL, 1/1/2002
  • Expression of P13- MTCP1 is restricted to T-cell Prolymphocytic Leukemia
    Madani A, Euro Cancer Conference, Paris, France, 1/1/1995

Press Mentions

  • Glendale Radiation Oncology Center Adds Doctor
    Glendale Radiation Oncology Center Adds DoctorAugust 13th, 2021
  • Deep Learning-Enabled Medical Computer Vision
    Deep Learning-Enabled Medical Computer VisionJanuary 8th, 2021

Professional Memberships

Other Languages

  • Arabic, French

Hospital Affiliations